Clinical Trial Update: Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED) [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating PegIntron plus ribavirin for chronic hepatitis C in HIV-infected subjects was terminated, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepacivirus | Phase 4 | Status: TERMINATED | Results posted: 2012-01-30